The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10237 malaria professionals are enjoying the free benefits of MalariaWorld today

antirelapse therapy

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019

November 30, 2019 - 20:08 -- Open Access
Author(s): 
Haston JC, Hwang J, Tan KR.
Reference: 
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1062-1068.

This report summarizes the published efficacy and safety evidence for the recommended doses for both indications and provides guidance for the use of tafenoquine in the United States. A more comprehensive review of the literature on tafenoquine along with the biologic rationale for its use has been published elsewhere (10).

Subscribe to RSS - antirelapse therapy